Letter: surveillance of Helicobacter pylori antibiotic resistance - authors' reply

被引：0
|
作者：
McNulty, C. A. M. [1 ]
Lasseter, G. [1 ]
Shaw, I. [2 ]
Nichols, T. [3 ]
D'Arcy, S. [4 ]
Lawson, A. J. [5 ]
Glocker, E. [6 ]
机构：
[1] Gloucestershire Royal Hosp, Hlth Protect Agcy, Primary Care Unit, Gloucester GL1 3NN, England
[2] Gloucestershire Hosp NHS Fdn Trust, Endoscopy Unit, Gloucester, England
[3] Hlth Protect Agcy, Stat Unit, London, England
[4] Publ Hlth Wales Microbiol Bangor, Bangor, Gwynedd, Wales
[5] HPA, Lab Gastrointestinal Pathogens, Helicobacter Reference Unit, London, England
[6] Univ Hosp Freiburg, Inst Med Microbiol & Hyg, Freiburg, Germany
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2012年 / 36卷 / 11-12期
关键词：
D O I：
10.1111/apt.12093
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1103 / 1103
页数：1
相关论文
共 50 条
  • [1] Letter: surveillance of Helicobacter pylori antibiotic resistance
    Porowska, B.
    Mascellino, M. T.
    Severi, C.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (11-12) : 1102 - 1102
  • [2] Letter: global emergence of Helicobacter pylori antibiotic resistance - unanswered questions. Authors' reply
    Thung, I.
    Crowe, S. E.
    Valasek, M. A.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (11) : 1249 - 1250
  • [3] Commentary: is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered? Authors' reply
    McNulty, C. A. M.
    Lasseter, G.
    Shaw, I.
    Nichols, T.
    D-Arcy, S.
    Lawson, A.
    Glocker, E.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (02) : 198 - 199
  • [4] Letter: levofloxacin resistance - a challenge for treatment of Helicobacter pylori infection. Authors' reply
    Chen, P. -Y.
    Wu, M. -S.
    Liou, J. -M.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (04) : 573 - 573
  • [5] Commentary: overcoming antibiotic resistance with Helicobacter pylori therapy - optimisation is the way forward; authors' reply
    Sierra, F.
    Forero, J. D.
    Rey, M.
    Botero, M. L.
    Cardenas, A.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (02) : 205 - 206
  • [6] Letter: curing Helicobacter pylori infection in a clinical setting authors' reply
    Thirriot, F.
    Tay, C. Y.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (07) : 758 - 759
  • [7] Letter: bismuth quadruple therapy with Pylera for Helicobacter pylori infection - authors' reply
    Malfertheiner, P.
    Delchier, J. C.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (06) : 736 - 737
  • [8] Functional and Molecular Surveillance of Helicobacter pylori Antibiotic Resistance in Kuala Lumpur
    Teh, Xinsheng
    Khosravi, Yalda
    Lee, Woon Ching
    Leow, Alex Hwong Ruey
    Loke, Mun Fai
    Vadivelu, Jamuna
    Goh, Khean Lee
    [J]. PLOS ONE, 2014, 9 (07):
  • [9] Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered?
    McNulty, C. A. M.
    Lasseter, G.
    Shaw, I.
    Nichols, T.
    D'Arcy, S.
    Lawson, A. J.
    Glocker, E.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (10) : 1221 - 1230
  • [10] Editorial: Helicobacter pylori resistance and sequential therapy-authors' reply
    Gatta, L.
    Scarpignato, C.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (01) : 96 - 97
12345